By Michael Dabaie

Zoetis Inc. (ZTS) said the European Commission granted marketing authorization for Simparica Trio chewable tablets, a once-monthly triple combination antiparasitic medication for dogs.

The marketing authorization follows a positive opinion adopted by the Committee for Medicinal Products for Veterinary Use in July.

Zoetis said it expects to launch Simparica Trio in the EU in the first quarter of 2020.

Shares were up about 1% in early trading.

Write to Michael Dabaie at michael.dabaie@wsj.com

(END) Dow Jones Newswires

September 20, 2019 09:54 ET (13:54 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Zoetis Charts.
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Zoetis Charts.